A. J. Nagy

Update on future headache treatments

A. Rapoport, A. J. Nagy, 2013, Neurological Sciences.

Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double‐blind studies

Qi Zhang, K. Schuh, S. Aurora, 2019, European journal of neurology.

Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2.

R. Cady, M. Janelidze, D. Buse, 2022, Clinical therapeutics.

Intravenous dihydroergotamine for inpatient management of refractory primary headaches

P. Goadsby, R. Bhola, S. Gandhi, 2011, Neurology.